The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Open accessAbstract
siRNA therapeutics have promise for the treatment of a wide range of genetic disorders. Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and selective siRNA carriers with a wide therapeutic index. Lead material cKK-E12 showed potent silencing effects in mice (ED50 ∼ 0.002 mg/kg), rats (ED50 < 0.01 mg/kg), and nonhuman primates (over 95% silencing at 0.3 mg/kg). Apolipoprotein E plays a significant role in the potency of cKK-E12 both in vitro and in vivo. cKK-E12 was highly selective toward liver parenchymal cell in vivo, with orders of magnitude lower doses needed to silence in hepatocytes compared with endothelial cells and immune cells in different organs. Toxicity studies showed that cKK-E12 was well tolerated in rats at a dose of 1 mg/kg (over 100-fold higher than the ED50). To our knowledge, this is the most efficacious and selective nonviral siRNA delivery system for gene silencing in hepatocytes reported to date.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The delivery of therapeutic RNA molecules (siRNA or microRNA) encapsulated within the lipid or lipid-like carrier231,232 into the cells or tissues was proven to be effective in infectious diseases and tumors, as shown in many preclinical studies233,234,235 and clinical trials (reviewed by Kaczmarek et al.236).”
From MiR-128-3p – a gray eminence of the human central nervous system (2024) · cites this paper as [233]
In the citing paper
“Some other LNPs were reported with organ specificity, such as cKK-E12 lipopeptide nanoparticles, wherein the lipid tails were conjugated to peptide derivatives and achieved liver targeting siRNA delivery.[67]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Self-citationRational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · cited 1×
“TTR, primarily synthesized in hepatocytes, plays significant roles in transporting thyroxine and retinol (10).”
BackgroundSelf-citationAbdel‐Magid, A. F., Carson, K. G., Harris, B. D., Maryanoff, C. A., & Shah, R. D. (1996) · The Journal of Organic Chemistry · doi:10.1021/jo960057x · Cited by 1,521
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261
Self-citationBio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,251
The promises and pitfalls of RNA-interference-based therapeutics
Castanotto, D., & Rossi, J. J. (2009) · Nature · doi:10.1038/nature07758 · Cited by 1,241
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150
Self-citationGenetic Heterogeneity in Human Disease
McClellan, J., & King, M.-C. (2010) · Cell · doi:10.1016/j.cell.2010.03.032 · Cited by 981
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 488
Polycations and their biomedical applications
Kim, K., Chen, W. C. W., Heo, Y., & Wang, Y. (2016) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2016.05.004 · Cited by 127
Yu, D., Khan, O. F., Suvà, M. L., Dong, B., Panek, W. K., Xiao, T., Wu, M., Han, Y., Ahmed, A. U., Balyasnikova, I. V., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701911114 · Cited by 123
Self-citationKhan, O. F., Kowalski, P. S., Doloff, J. C., Tsosie, J. K., Bakthavatchalu, V., Winn, C. B., Haupt, J. L., Jamiel, M., Langer, R., & Anderson, D. G. (2018) · Science Advances · doi:10.1126/sciadv.aar8409 · Cited by 120
Self-citationNanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell niche
Krohn-Grimberghe, M., Mitchell, M. J., Schloss, M. J., Khan, O. F., Courties, G., Guimarães, P. P. G., Rohde, D., Cremer, S., Kowalski, P. S., Sun, Y., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00623-7 · Cited by 123
Self-citationLam, K., Leung, A., Martin, A., Wood, M., Schreiner, P., Palmer, L., Daly, O. M., Zhao, W., McClintock, K., & Heyes, J. A. (2023) · Advanced Materials · doi:10.1002/adma.202209624 · Cited by 118
Nanoparticle Interactions with the Tumor Microenvironment
Huai, Y., Hossen, M. N., Wilhelm, S., Bhattacharya, R., & Mukherjee, P. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00448 · Cited by 113
Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo
Dong, Y., Dorkin, J. R., Wang, W., Chang, P., Webber, M. J., Tang, B. C., Yang, J., Ionita, I. A., Danino, D., DeRosa, F., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.5b02428 · Cited by 111
Self-citationCryo‐electron microscopy and cryo‐electron tomography of nanoparticles
Stewart, P. L. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1417 · Cited by 120
Improved Nucleic Acid Therapy with Advanced Nanoscale Biotechnology
Weng, Y., Huang, Q., Li, C., Yang, Y., Wang, X., Yu, J., Huang, Y., & Liang, X. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.004 · Cited by 110
Sato, Y., Kinami, Y., Hashiba, K., & Harashima, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.006 · Cited by 112
Biodegradable Amino-Ester Nanomaterials for Cas9 mRNA Delivery in Vitro and in Vivo
Zhang, X., Li, B., Luo, X., Zhao, W., Jiang, J., Zhang, C., Gao, M., Chen, X., & Dong, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b08163 · Cited by 107
Self-citationLipid Nanovesicles by Microfluidics: Manipulation, Synthesis, and Drug Delivery
Liu, C., Feng, Q., & Sun, J. (2018) · Advanced Materials · doi:10.1002/adma.201804788 · Cited by 107
Nienhaus, K., Wang, H., & Nienhaus, G. U. (2020) · Materials Today Advances · doi:10.1016/j.mtadv.2019.100036 · Cited by 107
Application of advances in endocytosis and membrane trafficking to drug delivery
Ju, Y., Guo, H., Edman, M. C., & Hamm‐Alvarez, S. F. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.026 · Cited by 110
Recent advances in nanoparticulate RNA delivery systems
Witten, J. J., Hu, Y., Langer, R., & Anderson, D. G. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307798120 · Cited by 113
Self-citationKauffman, K. J., Oberli, M. A., Dorkin, J. R., Hurtado, J. E., Kaczmarek, J. C., Bhadani, S., Wyckoff, J., Langer, R., Jaklenec, A., & Anderson, D. G. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.11.005 · Cited by 104
Self-citationTargeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors
Anthiya, S., Öztürk, S. C., Yanık, H., Tavukçuoğlu, E., Şahin, A., Datta, D., Charissé, K., Moreira, D., Loza, M. I., Calvo, A., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.03.016 · Cited by 102
Khan, O. F., Zaia, E. W., Yin, H., Bogorad, R. L., Pelet, J. M., Webber, M. J., Zhuang, I., Dahlman, J. E., Langer, R., & Anderson, D. G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201408221 · Cited by 101
Self-citationTang, C., Jing, W., Han, K. S., Yang, Z., Zhang, S., Liu, M., Zhang, J., Zhao, X., Liu, Y., Shi, C., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c10109 · Cited by 101
Lipid nanoparticles: Composition, formulation, and application
Xu, S., Hu, Z., Song, F., Xu, Y. G., & Han, X. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101463 · Cited by 115
Omo‐Lamai, S., Wang, Y., Patel, M. N., Milosavljevic, A., Zuschlag, D. W., Poddar, S., Wu, J., Wang, L., Dong, F., Espy, C. L., et al. (2025) · Nature Nanotechnology · doi:10.1038/s41565-025-01974-5 · Cited by 170
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
Melamed, J. R., Hajj, K. A., Chaudhary, N., Strelkova, D., Arral, M. L., Pardi, N., Alameh, M., Miller, J. B., Farbiak, L., Siegwart, D. J., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.022 · Cited by 101
Self-citationPlasma Protein Adsorption and Biological Identity of Systemically Administered Nanoparticles
Chen, D., Ganesh, S., Wang, W., & Amiji, M. M. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0178 · Cited by 102
Self-citationA Nanoprimer To Improve the Systemic Delivery of siRNA and mRNA
Saunders, N., Paolini, M. S., Fenton, O. S., Poul, L., Devallière, J., Mpambani, F., Darmon, A., Bergère, M., Jibault, O., Germain, M., et al. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c00752 · Cited by 99
Self-citationPoly(carboxybetaine) lipids enhance mRNA therapeutics efficacy and reduce their immunogenicity
Luozhong, S., Liu, P., Li, R., Yuan, Z., Debley, E. L., Chen, Y., Hu, Y., Cao, Z., Cui, M., McIlhenny, K., et al. (2025) · Nature Materials · doi:10.1038/s41563-025-02240-8 · Cited by 106
Self-citationThermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia
Hu, B., Li, B., Li, K., Liu, Y., Li, C., Zheng, L., Zhang, M., Yang, T., Guo, S., Dong, X., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm1418 · Cited by 95
Penetrating the Blood–Brain Barrier: Promise of Novel Nanoplatforms and Delivery Vehicles
Ali, I., & Chen, X. S. (2015) · ACS Nano · doi:10.1021/acsnano.5b05341 · Cited by 93
Recent Advances in RNA Therapeutics and RNA Delivery Systems Based on Nanoparticles
Shin, H., Park, S. D., Yim, Y., Kim, J., Choi, C., Won, C., & Min, D. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800065 · Cited by 95
Biomaterials as vectors for the delivery of CRISPR–Cas9
Eoh, J. H., & Gu, L. (2019) · Biomaterials Science · doi:10.1039/c8bm01310a · Cited by 92
Synthetic Nucleic Acid Delivery Systems: Present and Perspectives
Draghici, B., & Ilies, M. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm500330k · Cited by 90
Functional polyesters enable selective siRNA delivery to lung cancer over matched normal cells
Yan, Y., Liu, L., Xiong, H., Miller, J. B., Zhou, K., Kós, P., Huffman, K. E., Elkassih, S. A., Norman, J. W., Carstens, R. M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606886113 · Cited by 89
Self-citationSwitchable Lipids: Conformational Change for Fast pH‐Triggered Cytoplasmic Delivery
Viricel, W., Mbarek, A., & Chain, J. L. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201504661 · Cited by 95
Novel lipid combination for delivery of plasmid DNA to immune cells in the spleen
Kimura, S., Khalil, I. A., Elewa, Y. H. A., & Harashima, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.005 · Cited by 86
Rational design and combinatorial chemistry of ionizable lipids for RNA delivery
Xu, Y., Golubovic, A., Xu, S., Pan, A., & Li, B. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb00649b · Cited by 87
The role of protein corona on nanodrugs for organ-targeting and its prospects of application
Wang, S., Zhang, J., Zhou, H., Lu, Y. C., Jin, X., Luo, L., & Jian, Y. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.014 · Cited by 85
Xiong, H., Zuo, H., Yan, Y., Occhialini, G., Zhou, K., Wan, Y., & Siegwart, D. J. (2017) · Advanced Materials · doi:10.1002/adma.201700131 · Cited by 86
Self-citationLipid nanoparticles silence tumor necrosis factor α to improve wound healing in diabetic mice
Kasiewicz, L. N., & Whitehead, K. A. (2018) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10123 · Cited by 85
Petersen, D. M. S., Chaudhary, N., Arral, M. L., Weiss, R. M., & Whitehead, K. A. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.10.006 · Cited by 86
Nanoarchitectonics of biomolecular assemblies for functional applications
Avinash, M. B., & Govindaraju, T. (2014) · Nanoscale · doi:10.1039/c4nr04340e · Cited by 83
Testing thousands of nanoparticles in vivo using DNA barcodes
Lokugamage, M. P., Sago, C. D., & Dahlman, J. E. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2018.08.001 · Cited by 84
Vaidya, A., Moore, S., Chatterjee, S., Guerrero, E. D., Kim, M., Farbiak, L., Dilliard, S. A., & Siegwart, D. J. (2024) · Advanced Materials · doi:10.1002/adma.202313791 · Cited by 89
Self-citationBiomaterials in siRNA Delivery: A Comprehensive Review
Ho, W., Zhang, X., & Xu, X. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600418 · Cited by 85
RNA delivery biomaterials for the treatment of genetic and rare diseases
Zhao, W., Hou, X., Vick, O. G., & Dong, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119291 · Cited by 82
Self-citationCationic cholesterol-dependent LNP delivery to lung stem cells, the liver, and heart
Radmand, A., Kim, H., Beyersdorf, J. P., Dobrowolski, C. N., Zenhausern, R., Paunovska, K., Huayamares, S. G., Hua, X., Han, K., Loughrey, D., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307801120 · Cited by 84
Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery
Patel, S. K., Billingsley, M. M., Mukalel, A. J., Thatte, A. S., Hamilton, A. G., Gong, N., El-Mayta, R. D., Safford, H. C., Merolle, M. I., & Mitchell, M. J. (2023) · Theranostics · doi:10.7150/thno.89913 · Cited by 82
Cui, L., Hunter, M. R., Sonzini, S., Pereira, S. G. T., Romanelli, S. M., Liu, K., Li, W., Liang, L., Yang, B., Mahmoudi, N., et al. (2021) · Small · doi:10.1002/smll.202105832 · Cited by 78
Ralvenius, W. T., Andresen, J. L., Huston, M. M., Penney, J., Bonner, J. M., Fenton, O. S., Langer, R., & Tsai, L. (2024) · Advanced Materials · doi:10.1002/adma.202309225 · Cited by 78
Self-citationYang, T., Li, C., Wang, X., Zhao, D., Zhang, M., Cao, H., Liang, Z., Xiao, H., Liang, X., Weng, Y., et al. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.07.003 · Cited by 78
Enzyme-Responsive Charge-Reversal Polymer-Mediated Effective Gene Therapy for Intraperitoneal Tumors
Qiu, N., Gao, J., Liu, Q., Wang, J., & Shen, Y. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00440 · Cited by 78
Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing
Tang, H., Zhao, X., & Jiang, X. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.03.001 · Cited by 80
Bioinspired materials and technology for advanced cryopreservation
Dou, M., Lu, C., & Rao, W. (2021) · Trends in biotechnology · doi:10.1016/j.tibtech.2021.06.004 · Cited by 76
Nucleic acid therapeutics: Past, present, and future
Naeem, S., Zhang, J., Zhang, Y., & Wang, Y. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102440 · Cited by 81
Self-citationProtein and mRNA Delivery Enabled by Cholesteryl‐Based Biodegradable Lipidoid Nanoparticles
Li, Y., Jarvis, R., Zhu, K., Glass, Z., Ogurlu, R., Gao, P., Li, P., Chen, J., Yu, Y., Yang, Y., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004994 · Cited by 75
Li, Z., Zhang, X., Ho, W., Li, F., Gao, M., Bai, X., & Xu, X. (2022) · ACS Nano · doi:10.1021/acsnano.2c07822 · Cited by 79
Adityan, S., Tran, M. A., Bhavsar, C., & Wu, S. Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.016 · Cited by 75
Protein Binding Affinity of Polymeric Nanoparticles as a Direct Indicator of Their Pharmacokinetics
Cao, Z., Gan, L.-Q., Jiang, W., Wang, J., Zhang, H., Zhang, Y., Wang, Y., Yang, X., Xiong, M., & Wang, J. (2020) · ACS Nano · doi:10.1021/acsnano.9b10015 · Cited by 73
Self-citationSago, C. D., Lokugamage, M. P., Loughrey, D., Lindsay, K. E., Hincapie, R., Krupczak, B. R., Kalathoor, S., Sato, M., Echeverri, E. S., Fitzgerald, J. P., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00847-9 · Cited by 75
Ebrahimi, N., Manavi, M. S., Nazari, A., Momayezi, A., Faghihkhorasani, F., Abdulwahid, A. R. R., Rezaei‐Tazangi, F., Kavei, M., Rezaei, R., Mobarak, H., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117263 · Cited by 75
RetractedThe Therapeutic Potential of PTEN Modulation: Targeting Strategies from Gene to Protein
McLoughlin, N. M., Mueller, C., & Grossmann, T. N. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.10.009 · Cited by 74
He, Z., Le, Z., Shi, Y., Liu, L., Liu, Z., & Chen, Y. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202310401 · Cited by 72
Self-citationConde, J., Edelman, E. R., & Artzi, N. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.003 · Cited by 70
Nanoparticle stereochemistry-dependent endocytic processing improves in vivo mRNA delivery
Hatit, M. Z. C., Dobrowolski, C. N., Lokugamage, M. P., Loughrey, D., Ni, H., Zurla, C., Sanchez, A. J. D. S., Radmand, A., Huayamares, S. G., Zenhausern, R., et al. (2023) · Nature Chemistry · doi:10.1038/s41557-023-01138-9 · Cited by 71
Synthetic High-Density Lipoprotein-Like Nanoparticles as Cancer Therapy
McMahon, K. M., Foit, L., Angeloni, N. L., Giles, F. J., Gordon, L. I., & Thaxton, C. S. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-16555-4_6 · Cited by 69
Dunn, A. W., Kalinichenko, V. V., & Shi, D. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800876 · Cited by 69
Treating Cystic Fibrosis with mRNA and CRISPR
Sanchez, A. D. S., Paunovska, K., Cristian, A., & Dahlman, J. E. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.137 · Cited by 75
Size-Dependent Knockdown Potential of siRNA-Loaded Cationic Nanohydrogel Particles
Nuhn, L., Tomcin, S., Miyata, K., Mailänder, V., Landfester, K., Kataoka, K., & Zentel, R. (2014) · Biomacromolecules · doi:10.1021/bm501148y · Cited by 68
Yan, Y., Zhou, K., Xiong, H., Miller, J. B., Motea, E. A., Boothman, D. A., Liu, L., & Siegwart, D. J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.001 · Cited by 68
Self-citationInvestigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions
Reinhart, A.-G., Osterwald, A., Ringler, P., Leiser, Y., Lauer, M. E., Martin, R. E., Ullmer, C., Schumacher, F. F., Korn, C., & Keller, M. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00956 · Cited by 67
Hashiba, A., Toyooka, M., Sato, Y., Maeki, M., Tokeshi, M., & Harashima, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.031 · Cited by 66
Sun, M., Yang, C., Zheng, J., Wang, M., Chen, M., Le, D. Q. S., Kjems, J., & Bünger, C. E. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.09.029 · Cited by 65
Kasiewicz, L. N., & Whitehead, K. A. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.12.023 · Cited by 65
Structure-Based Design of Dendritic Peptide Bolaamphiphiles for siRNA Delivery
Zeng, H., Johnson, M. E., Oldenhuis, N. J., Tiambeng, T. N., & Guan, Z. (2015) · ACS Central Science · doi:10.1021/acscentsci.5b00233 · Cited by 64
Suzuki, Y., Hyodo, K., Suzuki, T., Tanaka, Y., Kikuchi, H., & Ishihara, H. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.016 · Cited by 64
Therapeutic RNA Delivery for COVID and Other Diseases
Dobrowolski, C. N., Paunovska, K., Hatit, M. Z. C., Lokugamage, M. P., & Dahlman, J. E. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002022 · Cited by 62
Yang, J., Duan, S., Ye, H., Ge, C., Piao, C., Chen, Y., Lee, M., & Yin, L. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202008960 · Cited by 62
Self-citationAdvances and prospects of RNA delivery nanoplatforms for cancer therapy
Attia, M. S., Kijanka, G. S., Nguyen, N., Zhang, J., & An, H. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.09.009 · Cited by 64
Ultrasound-Mediated Delivery of RNA to Colonic Mucosa of Live Mice
Schoellhammer, C. M., Lauwers, G. Y., Goettel, J. A., Oberli, M. A., Cleveland, C., Park, J. Y., Minahan, D. J., Chen, Y., Anderson, D. G., Jaklenec, A., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.002 · Cited by 62
Self-citationWerfel, T. A., Jackson, M. A., Kavanaugh, T. E., Kirkbride, K. C., Miteva, M., Giorgio, T. D., & Duvall, C. L. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.389 · Cited by 61
Nanoparticle protein corona evolution: from biological impact to biomarker discovery
Kamaly, N., Farokhzad, O. C., & Corbo, C. (2022) · Nanoscale · doi:10.1039/d1nr06580g · Cited by 65
Tissue-specific mRNA delivery and prime editing with peptide–ionizable lipid nanoparticles
Lin, Y., Li, M., Luo, Z., Meng, Y., Zong, Y., Ren, H., Yu, X., Tan, X., Liu, F., Wei, T., et al. (2025) · Nature Materials · doi:10.1038/s41563-025-02320-9 · Cited by 87
Nanotechnology in Drug Delivery for Liver Fibrosis
Gu, L., Zhang, F., Wu, J., & Zhuge, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.804396 · Cited by 61
Principles of lipid nanoparticle design for mRNA delivery
Zhang, Y., Zhang, X., Gao, Y., & Liu, S. (2024) · BMEMat · doi:10.1002/bmm2.12116 · Cited by 62
Self-citationYamamoto, S., Nishimura, K., Morita, K., Kanemitsu, S., Nishida, Y., Morimoto, T., Aoi, T., Tamura, A., & Maruyama, T. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00267 · Cited by 58
Targeting materials and strategies for RNA delivery
Lin, L., Su, K., Cheng, Q., & Liu, S. (2023) · Theranostics · doi:10.7150/thno.87316 · Cited by 61
Using macropinocytosis for intracellular delivery of therapeutic nucleic acids to tumour cells
Desai, A. S., Hunter, M. R., & Kapustin, A. N. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0156 · Cited by 58
Application of lipid-based nanoparticles in cancer immunotherapy
Zhang, Z., Yao, S., Hu, Y., Zhao, X. B., & Lee, R. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.967505 · Cited by 58
Dynamic carriers for therapeutic RNA delivery
Berger, S., Lächelt, U., & Wagner, E. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307799120 · Cited by 61
Suzuki, Y., & Ishihara, H. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.124 · Cited by 57
Sato, Y., Okabe, N., Note, Y., Hashiba, K., Maeki, M., Tokeshi, M., & Harashima, H. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.11.022 · Cited by 57
Yan, H., Zhu, D., Zhou, Z., Liu, X., Piao, Y., Zhang, Z., Liu, X., Tang, J., & Shen, Y. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.050 · Cited by 56
Emerging frontiers in drug delivery with special focus on novel techniques for targeted therapies
Yu, L., Liu, S., Jia, S., & Xu, F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115049 · Cited by 59
Next-generation materials for nucleic acid delivery
van der Meel, R., Wender, P. A., Merkel, O. M., Lostalé‐Seijo, I., Montenegro, J., Miserez, A., Laurent, Q., Sleiman, H. F., & Luciani, P. (2025) · Nature Reviews Materials · doi:10.1038/s41578-025-00814-1 · Cited by 68
Targeted endothelial nanomedicine for common acute pathological conditions
Shuvaev, V. V., Brenner, J. S., & Muzykantov, V. R. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.055 · Cited by 56
Recent advances in nanogels for drug delivery and biomedical applications
Vashist, A., Alvarez, G. P., Camargo, V. A., Raymond, A., Yndart, A., Kolishetti, N., Vashist, A., Manickam, P., Aggarwal, S., & Nair, M. (2024) · Biomaterials Science · doi:10.1039/d4bm00224e · Cited by 55
Cancer Nanotherapeutics in Clinical Trials
Lytton‐Jean, A. K. R., Kauffman, K. J., Kaczmarek, J. C., & Langer, R. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-16555-4_13 · Cited by 54
Self-citationAre RNAi and miRNA therapeutics truly dead?
Conde, J., & Artzi, N. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.12.005 · Cited by 55
Innate and adaptive immune responses toward nanomedicines
Viana, I. M. D. O., Roussel, S., Defrêne, J., Lima, E. M., Barabé, F., & Bertrand, N. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.022 · Cited by 57
Lipid nanoparticle-based mRNA candidates elicit potent T cell responses
Zeng, Y., Escalona-Rayo, O., Knol, R. A., Kros, A., & Slütter, B. (2022) · Biomaterials Science · doi:10.1039/d2bm01581a · Cited by 54
Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components
Wu, F., Li, N., Xiao, Y., Palanki, R., Yamagata, H. M., Mitchell, M. J., & Han, X. (2025) · Small Methods · doi:10.1002/smtd.202401632 · Cited by 64
McMahon, K. M., Plebanek, M. P., & Thaxton, C. S. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201602600 · Cited by 52
Metadata
- Authors
- Dong, Y., Love, K. T., Dorkin, J. R., Sirirungruang, S., Zhang, Y., Chen, D., Bogorad, R. L., Yin, H., Chen, Y., Vegas, A. J., Alabi, C. A., Sahay, G., Olejnik, K. T., Wang, W., Schroeder, A., Lytton-Jean, A. K. R., Siegwart, D. J., Akinc, A., Barnes, C., Barros, S. A., Carioto, M., Fitzgerald, K., Hettinger, J., Kumar, V., Novobrantseva, T. I., Qin, J., Querbes, W., Koteliansky, V., Langer, R., & Anderson, D. G.
- Affiliations
- Boston Children's Hospital (US)
- Massachusetts Institute of Technology (US)
- Koch Institute for Integrative Cancer Research At MIT (US)
- David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
- Alnylam Pharmaceuticals (United States) (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2014-02-10
- Volume
- 111
- Issue
- 11
- Pages
- 3955-3960
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3964096
- OpenAlex
- W2071030419
- Cited by
- 488
- References
- 35
- Citations by year
- 2026: 29 · 2025: 45 · 2024: 53 · 2023: 51 · 2022: 40 · 2021: 42 · 2020: 35 · 2019: 30 · 2018: 29 · 2017: 39 · 2016: 41 · 2015: 36 · 2014: 17
- FWCI
- 18.19
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-03-26)
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Funders
- Alnylam Pharmaceuticals
- National Institutes of Health (5r01de016516-10, 4r37eb000244-34, 5-R01-, 1f32eb017625-01, 5r01ca132091-04, CA151884, DE-016516, U54-CA151884, EB-000244, R01-EB000244-27, DE016516-03)
- National Heart, Lung, and Blood Institute (HHSN268201000045C)
- National Cancer Institute (5-R01-CA132091–04, U54CA151884, CA151884, R01-CA132091)
- National Institute of Biomedical Imaging and Bioengineering (R01-EB000244-27, EB-000244, R01EB000244, R37-EB000244, 1F32EB017625, F32 EB017625)
- National Institute of Dental and Craniofacial Research (R01DE016516-03)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- siRNA delivery, apolipoprotein E, hepatocyte targeting, liver parenchymal cells, siRNA therapeutics, toxicity, rodents, non-human primates, lipoproteins
- MeSH terms
- Animals, Apolipoproteins E, Macaca fascicularis, Drug Delivery Systems, Cryoelectron Microscopy, Gene Silencing, Hepatocytes, RNA, Small Interfering, Mice, Rats, Nanoparticles, Lipopeptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
